ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      16,867.60
      -0.80%
      Dow Jones
      38,460.92
      -0.11%
      Brent Oil
      87.435
      0.25%
      Bitcoin
      64,314.42
      0.05%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Rocket Pharmaceuticals Inc (RCKT)

      7. Rocket Pharmaceuticals Inc (RCKT) News

      RCKT

      Rocket Pharmaceuticals (RCKT)

      Rocket Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:RCKT
      DateTimeSourceHeadlineSymbolCompany
      04/02/20246:00AMBusiness WireRocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi AnemiaNASDAQ:RCKTRocket Pharmaceuticals Inc
      03/26/20244:01PMBusiness WireRocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership TeamNASDAQ:RCKTRocket Pharmaceuticals Inc
      03/04/20246:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      03/04/20246:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/29/20243:54PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/29/20242:59PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/26/20244:37PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/26/20244:01PMBusiness WireRocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent ProgressNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/21/20248:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/21/20248:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/21/20248:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/21/20248:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/21/20248:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/16/20245:28PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:RCKTRocket Pharmaceuticals Inc
      02/16/20244:37PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/16/20244:31PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/16/20244:26PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/16/20244:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/16/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/16/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/16/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/16/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/13/20244:37PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RCKTRocket Pharmaceuticals Inc
      02/13/20247:00AMBusiness WireRocket Pharmaceuticals Announces Update on FDA Review Timeline of KRESLADI™ (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)NASDAQ:RCKTRocket Pharmaceuticals Inc
      01/29/20243:26PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RCKTRocket Pharmaceuticals Inc
      01/23/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      01/22/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      01/22/20243:16PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
      01/02/20244:01PMBusiness WireRocket Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RCKTRocket Pharmaceuticals Inc
      12/13/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RCKTRocket Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:RCKT